{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T03:52:33Z","timestamp":1793505153863,"version":"4.5.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2022,9,28]],"date-time":"2022-09-28T00:00:00Z","timestamp":1664323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,9,28]],"date-time":"2022-09-28T00:00:00Z","timestamp":1664323200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Pediatr"],"DOI":"10.1007\/s00431-022-04628-z","type":"journal-article","created":{"date-parts":[[2022,9,28]],"date-time":"2022-09-28T11:03:52Z","timestamp":1664363032000},"page":"4175-4182","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["The association of salivary caffeine levels with serum concentrations in premature infants with apnea of prematurity"],"prefix":"10.1007","volume":"181","author":[{"given":"Ana","family":"Garc\u00eda-Robles","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1lvaro","family":"Solaz-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Verd\u00fa-Andr\u00e9s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Luis Poveda","family":"Andr\u00e9s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio Jos\u00e9","family":"Ca\u00f1ada-Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Consuelo Ch\u00e1fer","family":"Peric\u00e1s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry Daniel","family":"Ponce-Rodriguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e1ximo","family":"Vento","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pilar S\u00e1enz","family":"Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,9,28]]},"reference":[{"issue":"2","key":"4628_CR1","doi-asserted-by":"publisher","DOI":"10.7363\/020213","volume":"2","author":"P Paolillo","year":"2013","unstructured":"Paolillo P, Picone S (2013) Apnea of prematurity. J Pediatr Neonatal Individ Med JPNIM 2(2):e020213. https:\/\/doi.org\/10.7363\/020213","journal-title":"J Pediatr Neonatal Individ Med JPNIM"},{"key":"4628_CR2","doi-asserted-by":"publisher","unstructured":"Eichenwald EC (2016) Committee on fetus and newborn, American Academy of Pediatrics. Apnea of Prematurity. Pediatrics 137(1). https:\/\/doi.org\/10.1542\/peds.2015-3757","DOI":"10.1542\/peds.2015-3757"},{"key":"4628_CR3","doi-asserted-by":"publisher","unstructured":"Henderson-Smart DJ, De Paoli AG (2010) Methylxanthine treatment for apnoea in preterm infants. Cochrane Database Syst Rev (12):CD000140. https:\/\/doi.org\/10.1002\/14651858.CD000140.pub2","DOI":"10.1002\/14651858.CD000140.pub2"},{"issue":"5","key":"4628_CR4","doi-asserted-by":"publisher","first-page":"243","DOI":"10.5935\/MedicalExpress.2014.05.06","volume":"1","author":"GM Pacifici","year":"2014","unstructured":"Pacifici GM (2014) Clinical pharmacology of caffeine citrate in preterm infants. MedicalExpress 1(5):243\u2013250. https:\/\/doi.org\/10.5935\/MedicalExpress.2014.05.06","journal-title":"MedicalExpress"},{"key":"4628_CR5","unstructured":"Peyona-Summary of product characteristic. EMA-Europe. https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/peyona-epar-product-information_en.pdf. Accessed 17 Jan 2022"},{"key":"4628_CR6","doi-asserted-by":"publisher","unstructured":"Moschino L, Zivanovic S, Hartley C, Trevisanuto D, Baraldi E, Roehr CC (2020) Caffeine in preterm infants: where are we in 2020? ERJ Open Res 6(1). https:\/\/doi.org\/10.1183\/23120541.00330-2019","DOI":"10.1183\/23120541.00330-2019"},{"issue":"7","key":"4628_CR7","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1007\/s00431-015-2494-8","volume":"174","author":"S Mohammed","year":"2015","unstructured":"Mohammed S, Nour I, Shabaan AE, Shouman B, Abdel-Hady H, Nasef N (2015) High versus low-dose caffeine for apnea of prematurity: a randomized controlled trial. Eur J Pediatr 174(7):949\u2013956. https:\/\/doi.org\/10.1007\/s00431-015-2494-8","journal-title":"Eur J Pediatr"},{"issue":"6","key":"4628_CR8","doi-asserted-by":"publisher","first-page":"F523","DOI":"10.1136\/archdischild-2017-313556","volume":"103","author":"R Vliegenthart","year":"2018","unstructured":"Vliegenthart R, Miedema M, Hutten GJ, van Kaam AH, Onland W (2018) High versus standard dose caffeine for apnoea: a systematic review. Arch Dis Child Fetal Neonatal Ed 103(6):F523\u2013F529. https:\/\/doi.org\/10.1136\/archdischild-2017-313556","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"issue":"3","key":"4628_CR9","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1159\/000442813","volume":"109","author":"G Lista","year":"2016","unstructured":"Lista G, Fabbri L, Polackova R et al (2016) The real-world routine use of caffeine citrate in preterm infants: a European postauthorization safety study. Neonatology 109(3):221\u2013227. https:\/\/doi.org\/10.1159\/000442813","journal-title":"Neonatology"},{"issue":"6","key":"4628_CR10","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1097\/FTD.0b013e3181898b6f","volume":"30","author":"BG Charles","year":"2008","unstructured":"Charles BG, Townsend SR, Steer PA, Flenady VJ, Gray PH, Shearman A (2008) Caffeine citrate treatment for extremely premature infants with apnea: population pharmacokinetics, absolute bioavailability, and implications for therapeutic drug monitoring. Ther Drug Monit 30(6):709\u2013716. https:\/\/doi.org\/10.1097\/FTD.0b013e3181898b6f","journal-title":"Ther Drug Monit"},{"issue":"6","key":"4628_CR11","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1111\/bcp.13553","volume":"84","author":"L Hutchinson","year":"2018","unstructured":"Hutchinson L, Sinclair M, Reid B, Burnett K, Callan B (2018) A descriptive systematic review of salivary therapeutic drug monitoring in neonates and infants. Br J Clin Pharmacol 84(6):1089\u20131108. https:\/\/doi.org\/10.1111\/bcp.13553","journal-title":"Br J Clin Pharmacol"},{"key":"4628_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpba.2019.112914","volume":"178","author":"HD Ponce-Rodr\u00edguez","year":"2020","unstructured":"Ponce-Rodr\u00edguez HD, Garc\u00eda-Robles AA, S\u00e1enz-Gonz\u00e1lez P, Verd\u00fa-Andr\u00e9s J, Camp\u00edns-Falc\u00f3 P (2020) On-line in-tube solid phase microextraction coupled to capillary liquid chromatography-diode array detection for the analysis of caffeine and its metabolites in small amounts of biological samples. J Pharm Biomed Anal 178:112914. https:\/\/doi.org\/10.1016\/j.jpba.2019.112914","journal-title":"J Pharm Biomed Anal"},{"issue":"18","key":"4628_CR13","doi-asserted-by":"publisher","first-page":"4345","DOI":"10.1007\/s00216-014-7824-6","volume":"406","author":"J Kuligowski","year":"2014","unstructured":"Kuligowski J, Escobar J, Quint\u00e1s G et al (2014) Analysis of lipid peroxidation biomarkers in extremely low gestational age neonate urines by UPLC-MS\/MS. Anal Bioanal Chem 406(18):4345\u20134356. https:\/\/doi.org\/10.1007\/s00216-014-7824-6","journal-title":"Anal Bioanal Chem"},{"issue":"20","key":"4628_CR14","doi-asserted-by":"publisher","first-page":"2112","DOI":"10.1056\/NEJMoa054065","volume":"354","author":"B Schmidt","year":"2006","unstructured":"Schmidt B, Roberts RS, Davis P et al (2006) Caffeine therapy for apnea of prematurity. N Engl J Med 354(20):2112\u20132121. https:\/\/doi.org\/10.1056\/NEJMoa054065","journal-title":"N Engl J Med"},{"issue":"1","key":"4628_CR15","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1001\/jamapediatrics.2014.2223","volume":"169","author":"A Lodha","year":"2015","unstructured":"Lodha A, Seshia M, McMillan DD et al (2015) Association of early caffeine administration and neonatal outcomes in very preterm neonates. JAMA Pediatr 169(1):33\u201338. https:\/\/doi.org\/10.1001\/jamapediatrics.2014.2223","journal-title":"JAMA Pediatr"},{"issue":"2","key":"4628_CR16","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1038\/jp.2012.52","volume":"33","author":"RM Patel","year":"2013","unstructured":"Patel RM, Leong T, Carlton DP, Vyas-Read S (2013) Early caffeine therapy and clinical outcomes in extremely preterm infants. J Perinatol 33(2):134\u2013140. https:\/\/doi.org\/10.1038\/jp.2012.52","journal-title":"J Perinatol"},{"issue":"19","key":"4628_CR17","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1056\/NEJMoa073679","volume":"357","author":"B Schmidt","year":"2007","unstructured":"Schmidt B, Roberts RS, Davis P et al (2007) Long-term effects of caffeine therapy for apnea of prematurity. N Engl J Med 357(19):1893\u20131902. https:\/\/doi.org\/10.1056\/NEJMoa073679","journal-title":"N Engl J Med"},{"key":"4628_CR18","doi-asserted-by":"publisher","unstructured":"Lodha A, Entz R, Synnes A et al (2019) Early Caffeine Administration and Neurodevelopmental Outcomes in Preterm Infants. Pediatrics 143(1). https:\/\/doi.org\/10.1542\/peds.2018-1348","DOI":"10.1542\/peds.2018-1348"},{"issue":"6","key":"4628_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.siny.2020.101178","volume":"25","author":"V Saroha","year":"2020","unstructured":"Saroha V, Patel RM (2020) Caffeine for preterm infants: fixed standard dose, adjustments for age or high dose? Semin Fetal Neonatal Med 25(6):101178. https:\/\/doi.org\/10.1016\/j.siny.2020.101178","journal-title":"Semin Fetal Neonatal Med"},{"key":"4628_CR20","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.jpeds.2017.08.064","volume":"191","author":"G Koch","year":"2017","unstructured":"Koch G, Datta AN, Jost K, Schulzke SM, van den Anker J, Pfister M (2017) Caffeine citrate dosing adjustments to assure stable caffeine concentrations in preterm neonates. J Pediatr 191:50-56.e1. https:\/\/doi.org\/10.1016\/j.jpeds.2017.08.064","journal-title":"J Pediatr"},{"key":"4628_CR21","doi-asserted-by":"publisher","unstructured":"Kumral A, Tuzun F, Yesilirmak DC, Duman N, Ozkan H (2012) Genetic basis of apnoea of prematurity and caffeine treatment response: role of adenosine receptor polymorphisms: genetic basis of apnoea of prematurity. Acta Paediatr Oslo Nor 1992 101(7):e299\u2013303. https:\/\/doi.org\/10.1111\/j.1651-2227.2012.02664.x","DOI":"10.1111\/j.1651-2227.2012.02664.x"},{"issue":"3","key":"4628_CR22","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1016\/S0022-3476(80)80708-6","volume":"96","author":"NN Khanna","year":"1980","unstructured":"Khanna NN, Bada HS, Somani SM (1980) Use of salivary concentrations in the prediction of serum caffeine and theophylline concentrations in premature infants. J Pediatr 96(3):494\u2013499. https:\/\/doi.org\/10.1016\/S0022-3476(80)80708-6","journal-title":"J Pediatr"},{"issue":"3","key":"4628_CR23","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1097\/00007691-199606000-00012","volume":"18","author":"TC Lee","year":"1996","unstructured":"Lee TC, Charles BG, Steer PA, Flenady V (1996) Saliva as a valid alternative to serum in monitoring intravenous caffeine treatment for apnea of prematurity. Ther Drug Monit 18(3):288\u2013293. https:\/\/doi.org\/10.1097\/00007691-199606000-00012","journal-title":"Ther Drug Monit"},{"issue":"3","key":"4628_CR24","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1097\/00007691-200106000-00011","volume":"23","author":"SN de Wildt","year":"2001","unstructured":"de Wildt SN, Kerkvliet KT, Wezenberg MG et al (2001) Use of saliva in therapeutic drug monitoring of caffeine in preterm infants. Ther Drug Monit 23(3):250\u2013254. https:\/\/doi.org\/10.1097\/00007691-200106000-00011","journal-title":"Ther Drug Monit"},{"issue":"6","key":"4628_CR25","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/j.therap.2017.06.004","volume":"72","author":"A Chaabane","year":"2017","unstructured":"Chaabane A, Chioukh FZ, Chadli Z et al (2017) Therapeutic drug monitoring of caffeine in preterm infants: could saliva be an alternative to serum? Therapie 72(6):685\u2013689. https:\/\/doi.org\/10.1016\/j.therap.2017.06.004","journal-title":"Therapie"},{"key":"4628_CR26","doi-asserted-by":"publisher","unstructured":"Tracy MB, Klimek J, Hinder M, Ponnampalam G, Tracy SK (2010) Does caffeine impair cerebral oxygenation and blood flow velocity in preterm infants? Acta Paediatr Oslo Nor 1992 99(9):1319\u20131323. https:\/\/doi.org\/10.1111\/j.1651-2227.2010.01828.x","DOI":"10.1111\/j.1651-2227.2010.01828.x"},{"issue":"3","key":"4628_CR27","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1111\/bcp.13001","volume":"82","author":"NR Dobson","year":"2016","unstructured":"Dobson NR, Liu X, Rhein LM et al (2016) Salivary caffeine concentrations are comparable to plasma concentrations in preterm infants receiving extended caffeine therapy. Br J Clin Pharmacol 82(3):754\u2013761. https:\/\/doi.org\/10.1111\/bcp.13001","journal-title":"Br J Clin Pharmacol"}],"container-title":["European Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-022-04628-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00431-022-04628-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-022-04628-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,10]],"date-time":"2022-11-10T22:06:20Z","timestamp":1668117980000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00431-022-04628-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,28]]},"references-count":27,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["4628"],"URL":"https:\/\/doi.org\/10.1007\/s00431-022-04628-z","relation":{},"ISSN":["1432-1076"],"issn-type":[{"value":"1432-1076","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,28]]},"assertion":[{"value":"11 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 September 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was reviewed and approved by the Institutional Review Board of our hospital (approval identification code: GIP-CAF-2017\u201301\/408). Written informed consent was obtained from the parents of all patients before inclusion in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"All legal representatives of patients consent their participation after receiving patient information and consents.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The authors confirm that if their article is published in ANC, they will notify the relevant parties accordingly so that the preprint version can be linked to the published record.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclaimer"}}]}}